Skip to main content
. 2022 May 4;15(6):594–599. doi: 10.1136/neurintsurg-2022-018958

Table 2.

Summary of the results of the qualitative analysis by two different readers

Liquid embolic agent Onyx 18 Squid 18 Squid 12 PHIL 25% PHIL LV
Diameter 2.0 mm
NBCA/iodized oil p>0.999 p>0.999 p>0.999 p<0.001 p=0.002
PHIL LV N/A N/A p=0.002 p>0.999
PHIL 25% p<0.001 p<0.001 N/A
Squid 18 p>0.999 N/A p>0.999
Diameter 1.5 mm
NBCA/iodized oil p>0.999 p>0.999 p=0.579 p<0.001 p<0.001
PHIL LV N/A N/A p=0.162 p>0.999
PHIL 25% p<0.001 p<0.001 N/A
Squid 18 p>0.999 N/A p=0.579
Diameter 1.0 mm
NBCA/iodized oil p>0.999 p>0.999 p>0.999 p=0.003 p<0.001
PHIL LV N/A N/A p=0.101 p>0.999
PHIL 25% p=0.001 p=0.034 N/A
Squid 18 p>0.999 N/A p>0.999

Bold type indicates statistical significance.

N/A: no p value available since the Dunn’s test was only performed for corresponding LEA variants.

LEA, liquid embolic agent; LV, low viscosity; NBCA, n-butyl cyanoacrylate; PHIL, precipitating hydrophobic injectable liquid.